ID

34861

Descripción

An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence; ODM derived from: https://clinicaltrials.gov/show/NCT02296970

Link

https://clinicaltrials.gov/show/NCT02296970

Palabras clave

Versiones (1)
  1. 1/2/19 1/2/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

1 de febrero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Basal Cell Carcinoma NCT02296970

Inglés

Eligibility Basal Cell Carcinoma NCT02296970

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients 18 years or older that are determined by an investigator to have a lesion that is highly likely to be a bcc, less than or equal to 1.0cm in largest diameter, based on clinical examination located in the trunk or extremities, proximal to the wrist and ankles
Descripción

Age | Lesion Very likely Basal cell carcinoma | Lesion Diameter Largest | Location of lesion Trunk | Location of lesion Extremities Proximal Wrist | Location of lesion Extremities Proximal Ankle

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0221198
UMLS CUI [2,2]
C3840799
UMLS CUI [2,3]
C0007117
UMLS CUI [3,1]
C0221198
UMLS CUI [3,2]
C1301886
UMLS CUI [3,3]
C0443228
UMLS CUI [4,1]
C2184261
UMLS CUI [4,2]
C0460005
UMLS CUI [5,1]
C2184261
UMLS CUI [5,2]
C0015385
UMLS CUI [5,3]
C0205107
UMLS CUI [5,4]
C0043262
UMLS CUI [6,1]
C2184261
UMLS CUI [6,2]
C0015385
UMLS CUI [6,3]
C0205107
UMLS CUI [6,4]
C0003086
subject is able to give informed consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
subject is able to commit to 6 month follow up visit
Descripción

Follow-up Duration Commitment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3274571
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C0870312
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
bcc > 1cm in diameter on any one axis.
Descripción

Basal cell carcinoma Diameter Axis Any

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007117
UMLS CUI [1,2]
C1301886
UMLS CUI [1,3]
C1522496
UMLS CUI [1,4]
C1552551
immunosuppressed patients
Descripción

Therapeutic immunosuppression

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021079
subjects with neutropenia
Descripción

Neutropenia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027947
organ transplant patients
Descripción

Organ Transplantation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0029216
subjects with a life expectancy less than year
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
patients taking immunosuppressive medications, including prednisone at a dose of 10mg or greater with an expected duration greater than 4 weeks, azathioprine, mycophenolate mofetil, cyclosporine, oral tacrolimus, any tumor necrosis factor (tnf)-alpha inhibitor, ustekinumab, rituximab, or any other medication in the judgement of the investigator could results in clinically meaningful immunosuppression of the subject
Descripción

Immunosuppressive Agents | Prednisone Dosage | Azathioprine | mycophenolate mofetil | Cyclosporine | Tacrolimus Oral Product | TNF-alpha inhibitor | ustekinumab | rituximab

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021081
UMLS CUI [2,1]
C0032952
UMLS CUI [2,2]
C0178602
UMLS CUI [3]
C0004482
UMLS CUI [4]
C0209368
UMLS CUI [5]
C0010592
UMLS CUI [6]
C1273163
UMLS CUI [7]
C1562242
UMLS CUI [8]
C1608841
UMLS CUI [9]
C0393022
basal cell carcinomas that have infiltrative or morpheaform characteristics based on clinical examination
Descripción

Basal cell carcinoma infiltrative Clinical examination | Morpheic basal cell carcinoma Clinical examination

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1304298
UMLS CUI [1,2]
C1456356
UMLS CUI [2,1]
C0555191
UMLS CUI [2,2]
C1456356
subjects unable to provide informed consent
Descripción

Informed Consent Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
subjects unable to commit to 6 month follow up
Descripción

Follow-up Duration Commitment Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3274571
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C0870312
UMLS CUI [1,4]
C1299582
Volver a la parte superior de la página

Similar models

Eligibility Basal Cell Carcinoma NCT02296970

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age | Lesion Very likely Basal cell carcinoma | Lesion Diameter Largest | Location of lesion Trunk | Location of lesion Extremities Proximal Wrist | Location of lesion Extremities Proximal Ankle
Item
patients 18 years or older that are determined by an investigator to have a lesion that is highly likely to be a bcc, less than or equal to 1.0cm in largest diameter, based on clinical examination located in the trunk or extremities, proximal to the wrist and ankles
boolean
C0001779 (UMLS CUI [1])
C0221198 (UMLS CUI [2,1])
C3840799 (UMLS CUI [2,2])
C0007117 (UMLS CUI [2,3])
C0221198 (UMLS CUI [3,1])
C1301886 (UMLS CUI [3,2])
C0443228 (UMLS CUI [3,3])
C2184261 (UMLS CUI [4,1])
C0460005 (UMLS CUI [4,2])
C2184261 (UMLS CUI [5,1])
C0015385 (UMLS CUI [5,2])
C0205107 (UMLS CUI [5,3])
C0043262 (UMLS CUI [5,4])
C2184261 (UMLS CUI [6,1])
C0015385 (UMLS CUI [6,2])
C0205107 (UMLS CUI [6,3])
C0003086 (UMLS CUI [6,4])
Informed Consent
Item
subject is able to give informed consent
boolean
C0021430 (UMLS CUI [1])
Follow-up Duration Commitment
Item
subject is able to commit to 6 month follow up visit
boolean
C3274571 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0870312 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Basal cell carcinoma Diameter Axis Any
Item
bcc > 1cm in diameter on any one axis.
boolean
C0007117 (UMLS CUI [1,1])
C1301886 (UMLS CUI [1,2])
C1522496 (UMLS CUI [1,3])
C1552551 (UMLS CUI [1,4])
Therapeutic immunosuppression
Item
immunosuppressed patients
boolean
C0021079 (UMLS CUI [1])
Neutropenia
Item
subjects with neutropenia
boolean
C0027947 (UMLS CUI [1])
Organ Transplantation
Item
organ transplant patients
boolean
C0029216 (UMLS CUI [1])
Life Expectancy
Item
subjects with a life expectancy less than year
boolean
C0023671 (UMLS CUI [1])
Immunosuppressive Agents | Prednisone Dosage | Azathioprine | mycophenolate mofetil | Cyclosporine | Tacrolimus Oral Product | TNF-alpha inhibitor | ustekinumab | rituximab
Item
patients taking immunosuppressive medications, including prednisone at a dose of 10mg or greater with an expected duration greater than 4 weeks, azathioprine, mycophenolate mofetil, cyclosporine, oral tacrolimus, any tumor necrosis factor (tnf)-alpha inhibitor, ustekinumab, rituximab, or any other medication in the judgement of the investigator could results in clinically meaningful immunosuppression of the subject
boolean
C0021081 (UMLS CUI [1])
C0032952 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0004482 (UMLS CUI [3])
C0209368 (UMLS CUI [4])
C0010592 (UMLS CUI [5])
C1273163 (UMLS CUI [6])
C1562242 (UMLS CUI [7])
C1608841 (UMLS CUI [8])
C0393022 (UMLS CUI [9])
Basal cell carcinoma infiltrative Clinical examination | Morpheic basal cell carcinoma Clinical examination
Item
basal cell carcinomas that have infiltrative or morpheaform characteristics based on clinical examination
boolean
C1304298 (UMLS CUI [1,1])
C1456356 (UMLS CUI [1,2])
C0555191 (UMLS CUI [2,1])
C1456356 (UMLS CUI [2,2])
Informed Consent Unable
Item
subjects unable to provide informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Follow-up Duration Commitment Unable
Item
subjects unable to commit to 6 month follow up
boolean
C3274571 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0870312 (UMLS CUI [1,3])
C1299582 (UMLS CUI [1,4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial